Estimates Revisions Takeda Pharmaceutical Company Limited Boerse Muenchen
Stocks
TKD
JP3463000004
Pharmaceuticals
|
Market Closed -
Boerse Muenchen
16:44:19 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 31.74 EUR | -0.78% |
|
+1.85% | +21.54% |
| 09-04 | After obesity, pharma seeks its next mega-blockbuster in sleep |  |
| 09-04 | Takeda Pharmaceutical Insider Sold Shares Worth $2,148,372, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 4502 Stock
- TKD Stock
- Consensus Takeda Pharmaceutical Company Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
